Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
30% Topical Hydrogen Peroxide for Non-melanoma Skin Cancers
NCT04929535Phase 2Unknown
- Start
- Sep 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in basal cell carcinoma (BCC), Squamous Cell Carcinoma of the Skin (SCC). Status: unknown.
02
Drugs
hydrogen peroxide gel
03
Conditions
basal cell carcinoma (BCC)Squamous Cell Carcinoma of the Skin (SCC)
Beyond the preview
Go deeper on NCT04929535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04929535.